Education
About Us
Working with TipRanks
Follow Us
Vitrolife AB (GB:0YAY)
LSE:0YAY
0YAY Stock Chart & Stats
kr137.87
-kr1.80(-0.60%)
At close: 4:00 PM EDT
kr137.87
-kr1.80(-0.60%)
Day’s Range― - ―
52-Week Rangekr126.10 - kr243.00
Previous CloseN/A
Volume1.22K
Average Volume (3M)4.96K
Market Cap
kr18.68B
Enterprise Valuekr18.46B
Total Cash (Recent Filing)kr1.11B
Total Debt (Recent Filing)kr2.00B
Price to Earnings (P/E)42.3
Beta0.74
Next Earnings
Feb 03, 2026EPS Estimate
1.02Next Dividend Ex-DateN/A
Dividend Yield5.27%
Share Statistics
EPS (TTM)0.75
Shares Outstanding135,447,190
10 Day Avg. Volume4,001
30 Day Avg. Volume4,957
Financial Highlights & Ratios
PEG Ratio-0.50
Price to Book (P/B)2.13
Price to Sales (P/S)8.07
P/FCF Ratio32.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Vitrolife AB News
0YAY FAQ
What was Vitrolife AB’s price range in the past 12 months?
Vitrolife AB lowest share price was kr126.10 and its highest was kr243.00 in the past 12 months.
What is Vitrolife AB’s market cap?
Vitrolife AB’s market cap is kr18.68B.
When is Vitrolife AB’s upcoming earnings report date?
Vitrolife AB’s upcoming earnings report date is Feb 03, 2026 which is in 36 days.
How were Vitrolife AB’s earnings last quarter?
Vitrolife AB released its earnings results on Oct 23, 2025. The company reported kr0.75 earnings per share for the quarter, missing the consensus estimate of kr0.947 by -kr0.197.
Is Vitrolife AB overvalued?
According to Wall Street analysts Vitrolife AB’s price is currently Overvalued.
Does Vitrolife AB pay dividends?
Vitrolife AB pays a Annually dividend of kr10.54 which represents an annual dividend yield of 5.27%. See more information on Vitrolife AB dividends here
What is Vitrolife AB’s EPS estimate?
Vitrolife AB’s EPS estimate is 1.02.
How many shares outstanding does Vitrolife AB have?
Vitrolife AB has 135,447,190 shares outstanding.
What happened to Vitrolife AB’s price movement after its last earnings report?
Vitrolife AB reported an EPS of kr0.75 in its last earnings report, missing expectations of kr0.947. Following the earnings report the stock price went up 2.712%.
Which hedge fund is a major shareholder of Vitrolife AB?
Currently, no hedge funds are holding shares in GB:0YAY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vitrolife AB
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.
Technical Analysis
Getinge
―
BICO Group AB Class B
―
CellaVision AB
―
Xvivo Perfusion AB
―
Sectra AB Class B
―
Options Prices
Currently, No data available
---